Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tympanogen logo — Sound design. Transformative care.

Tympanogen

Sound design. Transformative care.

Founded 2014 United States Richmond, United States 8 employees Venture round Total: $3.29M Biotechnology, Health Care +1

General Information

Company Name Tympanogen
Founded Year 2014
Location United States Richmond, United States
Employees 8
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Tympanogen. To contact Tympanogen, visit tympanogen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Tympanogen

Tympanogen, founded in 2014 in the United States, focuses on medical technology, particularly in the ear, nose, and throat (ENT) devices and wound-healing therapies. The company’s flagship product, Perf-Fix nonsurgical gel patch, aims to revolutionize traditional tympanoplasty procedures, offering quick office visits as a viable alternative. Tympanogen's innovative approach not only simplifies existing procedures but also endeavors to enhance treatment outcomes in the biotechnology and healthcare industries. Additionally, Tympanogen actively engages in groundbreaking research aboard the International Space Station, contributing to advancements in material science and space medicine. The company's recent milestone includes a significant investment of $1.00M in a Venture Round on April 4, 2022, with NO/LA Angel Network as the investor. Tympanogen's commitment to redefining the medical technology landscape, along with its strategic partnerships and forward-thinking research initiatives, positions it as a promising venture for potential investors seeking opportunities in the health and biotechnology sectors.

Taxonomy: ENT devices, wound-healing therapies, tympanoplasty procedures, nonsurgical gel patch, International Space Station, material science, space medicine, novel materials, treatment outcomes, healthcare costs, otolaryngologists, eardrum repair

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.00M 1
NO/LA Angel Network
NO/LA Angel Network
04 Apr 2022
Grant $737.37K 1
Virginia Catalyst
01 Nov 2021
Convertible Note Undisclosed 1
ShockVentures
ShockVentures
14 Oct 2021
Grant $75.00K -
17 Jun 2020
Grant $1.48M 1
National Institute of Deafness & Communications Disorders (NIDCD)
19 Aug 2019
Venture Round Undisclosed 1
Virginia Venture Partners
28 Feb 2019
Non Equity Assistance Undisclosed 1
MassChallenge
MassChallenge
19 May 2016

Tympanogen Alternatives & Competitors

Tympanogen vs
ABK Biomedical Inc.
ABK Biomedical Inc. Canada

Improving treatment options for patients with hypervascular tumors

Series C
42 employees
Biotechnology, Health Care

FAQ About Tympanogen

Sound design. Transformative care.
Tympanogen was founded in 2014.
Tympanogen is headquartered in Richmond, United States.
Tympanogen operates in Biotechnology, Health Care and Medical Devices. Its work centres on ENT devices, wound-healing therapies, tympanoplasty procedures and nonsurgical gel patch.
Tympanogen has approximately 8 employees.
Tympanogen has completed 7 funding rounds, raising a total of $3.29M. The latest funding stage is Venture round.
Top alternatives and competitors to Tympanogen include ABK Biomedical Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tympanogen and ABK Biomedical Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tympanogen, https://bouncewatch.com/company/tympanogen, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes